Group One Trading, L.P. Relay Therapeutics, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$7.5 - $12.07 $5,985 - $9,631	-798 Reduced 77.7%	229 $1,000
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $8,209 - $15,681	-1,366 Reduced 57.08%	1,027 $11,000
Q3 2023 Nov 09, 2023	SELL	$8.24 - $12.97 $13,727 - $21,608	-1,666 Reduced 41.04%	2,393 $20,000
Q2 2023 Aug 09, 2023	BUY	$9.99 - $18.27 $40,199 - $73,518	4,024 Added 11497.14%	4,059 $50,000
Q1 2023 May 12, 2023	BUY	$15.0 - $22.76 $525 - $796	35 New	35 $0

182

126M

1.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $780M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.